PBS updates

Lacosamide ARX (Lacosamide)

lacosamide 200 mg tablet, 56 · ORAL · PBS code 12658F

STREAMLINED

What it costs

AU$91.3 PBS-determined price per 56 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2022-11-01.
  • • Repeats: 5.
  • • PBS program: GE.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Idiopathic generalised epilepsy with primary generalised tonic-clonic seizures


Must be treated by a neurologist; or

Must be treated by a paediatrician; or

Must be treated by an eligible practitioner type who has consulted at least one of the above mentioned specialist types, with agreement reached that the patient should be treated with this pharmaceutical benefit on this occasion; AND

The condition must have failed to be controlled satisfactorily by at least two antiseizure medications prior to when the drug is/was first commenced; AND

The treatment must be (for initiating treatment)/have been (for continuing treatment) in combination with at least one PBS-subsidised antiseizure medication at the time the drug is/was first commenced.

Sponsor: Arrotex Pharmaceuticals Pty Ltd ABN 30 605 552 234

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.